Q2 2014 13F Holders as of 30 Jun 2014
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
61,032,652
-
Share change
-
+6,332,058
-
Total reported value
-
$1,829,399,090
-
Put/Call ratio
-
113%
-
Price per share
-
$29.99
-
Number of holders
-
181
-
Value change
-
+$194,997,573
-
Number of buys
-
89
-
Number of sells
-
95
Institutional Holders of IMPAX LABORATORIES INC - COM (IPXL) as of Q2 2014
As of 30 Jun 2014,
IMPAX LABORATORIES INC - COM (IPXL) was held by
181 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
61,032,652 shares.
The largest 10 holders included
ORBIMED ADVISORS LLC, BlackRock Fund Advisors, VANGUARD GROUP INC, FMR LLC, Invesco Ltd., State Street Corp, UBS GLOBAL ASSET MANAGEMENT AMERICAS INC, BlackRock Institutional Trust Company, N.A., JENNISON ASSOCIATES LLC, and Ameriprise Financial Inc.
This page lists
181
institutional shareholders reporting positions in this security
for the Q2 2014 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.